Eva P. Cuevas

947 total citations
22 papers, 767 citations indexed

About

Eva P. Cuevas is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Eva P. Cuevas has authored 22 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Neurology and 6 papers in Physiology. Recurrent topics in Eva P. Cuevas's work include Alzheimer's disease research and treatments (6 papers), Microbial metabolism and enzyme function (6 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Eva P. Cuevas is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Microbial metabolism and enzyme function (6 papers) and Amyotrophic Lateral Sclerosis Research (5 papers). Eva P. Cuevas collaborates with scholars based in Spain, Chile and United States. Eva P. Cuevas's co-authors include Francisco Portillo, Amparo Cano, Gema Moreno‐Bueno, Vanesa Santos, Katalin Csiszár, Héctor Peinado, Giacomo Canesin, Pilar Eraso, Alberto Martín and Marı́a J. Mazón and has published in prestigious journals such as Angewandte Chemie International Edition, The EMBO Journal and PLoS ONE.

In The Last Decade

Eva P. Cuevas

22 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva P. Cuevas Spain	13	581	179	134	105	88	22	767
C. Leah B. Kline United States	16	566 1.0×	298 1.7×	159 1.2×	97 0.9×	108 1.2×	25	855
Antonella N. Witmer Netherlands	10	965 1.7×	198 1.1×	183 1.4×	76 0.7×	106 1.2×	12	1.8k
Shruti Desai United States	13	476 0.8×	144 0.8×	208 1.6×	87 0.8×	63 0.7×	28	692
R M de Waal Netherlands	10	464 0.8×	205 1.1×	144 1.1×	80 0.8×	113 1.3×	12	821
Brunella Cristofaro United Kingdom	10	434 0.7×	134 0.7×	88 0.7×	52 0.5×	79 0.9×	14	730
Ian D. Tonks Australia	17	929 1.6×	277 1.5×	169 1.3×	75 0.7×	227 2.6×	26	1.3k
Miriam Rábano Spain	9	467 0.8×	265 1.5×	172 1.3×	46 0.4×	62 0.7×	17	689
Sonia Pagliardini Italy	17	610 1.0×	312 1.7×	133 1.0×	146 1.4×	100 1.1×	25	988
Daniel L. Altschuler United States	22	1.0k 1.8×	294 1.6×	115 0.9×	103 1.0×	145 1.6×	35	1.6k
Hong Chang United States	13	463 0.8×	346 1.9×	118 0.9×	41 0.4×	60 0.7×	18	829

Countries citing papers authored by Eva P. Cuevas

Since Specialization

Citations

This map shows the geographic impact of Eva P. Cuevas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva P. Cuevas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva P. Cuevas more than expected).

Fields of papers citing papers by Eva P. Cuevas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva P. Cuevas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva P. Cuevas. The network helps show where Eva P. Cuevas may publish in the future.

Co-authorship network of co-authors of Eva P. Cuevas

This figure shows the co-authorship network connecting the top 25 collaborators of Eva P. Cuevas. A scholar is included among the top collaborators of Eva P. Cuevas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva P. Cuevas. Eva P. Cuevas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cuevas, Eva P., Enrique López Madruga, David Ramírez, et al.. (2025). MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. Neurobiology of Disease. 208. 106871–106871. 2 indexed citations

Cuevas, Eva P., Loreto Martínez‐González, Amets Sáenz, et al.. (2024). Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis. Neurobiology of Disease. 192. 106430–106430. 9 indexed citations

Nozal, Vanesa, Alfonso García‐Rubia, Loreto Martínez‐González, et al.. (2024). Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation. Biomedicine & Pharmacotherapy. 175. 116626–116626. 3 indexed citations

Martínez‐González, Loreto, Eva P. Cuevas, Vanesa Nozal, et al.. (2023). TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients. Frontiers in Molecular Neuroscience. 16. 1243277–1243277. 9 indexed citations

Eraso, Pilar, Marı́a J. Mazón, Victoria Jiménez, et al.. (2023). New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins. Molecules. 28(11). 4433–4433. 4 indexed citations

Nozal, Vanesa, Loreto Martínez‐González, Paula Santana, et al.. (2022). TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. Journal of Medicinal Chemistry. 65(2). 1585–1607. 28 indexed citations

Cuevas, Eva P., et al.. (2022). TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer’s Disease Patients. Biomedicines. 10(2). 385–385. 5 indexed citations

Guijarro, Luis G., Eva P. Cuevas, M. Val Toledo-Lobo, et al.. (2021). Possible Role of IRS-4 in the Origin of Multifocal Hepatocellular Carcinoma. Cancers. 13(11). 2560–2560. 11 indexed citations

Guijarro, Luis G., Eva P. Cuevas, M. Val Toledo-Lobo, et al.. (2021). Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4. Pharmaceuticals. 14(9). 845–845. 8 indexed citations

10.

Nozal, Vanesa, Alfonso García‐Rubia, Eva P. Cuevas, et al.. (2021). From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis. Angewandte Chemie International Edition. 60(35). 19344–19354. 15 indexed citations

11.

Martínez‐González, Loreto, et al.. (2020). Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP‐43‐related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Journal of Neurochemistry. 156(3). 379–390. 23 indexed citations

12.

Cuevas, Eva P., Pilar Eraso, Marı́a J. Mazón, et al.. (2017). LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway. Scientific Reports. 7(1). 44988–44988. 87 indexed citations

13.

Martín, Alberto, Fernando Salvador, Gema Moreno‐Bueno, et al.. (2015). Lysyl oxidase‐like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. The EMBO Journal. 34(8). 1090–1109. 74 indexed citations

14.

Canesin, Giacomo, Eva P. Cuevas, Celia López‐Menéndez, et al.. (2014). Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization. Oncogene. 34(8). 951–964. 76 indexed citations

15.

Díaz‐López, Antonio, Juan Díaz‐Martín, Gema Moreno‐Bueno, et al.. (2014). Zeb1 and Snail1 engage miR‐200f transcriptional and epigenetic regulation during EMT. International Journal of Cancer. 136(4). E62–73. 54 indexed citations

16.

Cuevas, Eva P., Gema Moreno‐Bueno, Giacomo Canesin, et al.. (2014). LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition. Biology Open. 3(2). 129–137. 53 indexed citations

17.

Cubillo, Eva, Antonio Díaz‐López, Eva P. Cuevas, et al.. (2013). E47 and Id1 Interplay in Epithelial-Mesenchymal Transition. PLoS ONE. 8(3). e59948–e59948. 45 indexed citations

18.

Cuevas, Eva P., Óscar Escribano, Jorge Monserrat, et al.. (2009). RNAi‐mediated silencing of insulin receptor substrate‐4 enhances actinomycin D‐ and tumor necrosis factor‐α‐induced cell death in hepatocarcinoma cancer cell lines. Journal of Cellular Biochemistry. 108(6). 1292–1301. 16 indexed citations

19.

Armesilla-Diaz, Alejandro, Paloma Bragado, Ignacio del Valle, et al.. (2008). p53 regulates the self-renewal and differentiation of neural precursors. Neuroscience. 158(4). 1378–1389. 75 indexed citations

20.

Cuevas, Eva P., Óscar Escribano, Antonio Chiloeches, et al.. (2007). Role of insulin receptor substrate-4 in IGF-I-stimulated HEPG2 proliferation. Journal of Hepatology. 46(6). 1089–1098. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact